Journal of Neuroscience retracts federally funded Canadian study with “substantial data misrepresentation”

The Journal of Neuroscience is retracting a paper by researchers at Memorial University in Newfoundland, Canada, after a university investigation found “substantial data misrepresentation” in the work, which was funded by two major federal agencies.

Here’s the notice: Continue reading Journal of Neuroscience retracts federally funded Canadian study with “substantial data misrepresentation”

Three more retractions for weight loss surgeon Edward Shang for making up data

Edward Shang, the weight loss surgeon who lost his job at the University of Leipzig in May after it was revealed that he had made up most, if not all, of the patients in his research studies at the University of Mannheim, has retracted three more papers.

Here’s the notice, which is a bit, um, lean, given what we know about the case: Continue reading Three more retractions for weight loss surgeon Edward Shang for making up data

Former Millennium Villages Project staffer responds to critical Nature editorial

courtesy Nature

Last week, we wrote about a correction of a heavily criticized paper in The Lancet by the Millennium Villages Project, a large aid program. Paul Pronyk, director of monitoring and evaluation at Columbia University’s Center for Global Health and Economic Development, which runs the Project, left his job shortly after writing an explanatory letter that accompanied the correction.

That correction had come after a letter to The Lancet, but also after Nature had raised issues in an editorial. Nature’s editorial concluded: Continue reading Former Millennium Villages Project staffer responds to critical Nature editorial

Why retraction notices matter: Group’s repeated misuse of figures gets different play from five journals

For some journals, thorough retraction notices are the rule — and, when misconduct is involved, the price authors pay for abusing the trust of the editors and the readers. Others seem to take a more casual approach. Guess which we think is best.

Consider the case of a group of researchers in China led by Tan Jinquan, an immune system expert at Wuhan University. Over the past two years or so, Jinquan and colleagues have lost no fewer than a half-dozen papers containing evidence of image manipulation. But, depending on the journal pulling the articles, you might not know it.

Continue reading Why retraction notices matter: Group’s repeated misuse of figures gets different play from five journals

Not for the faint of heart: Cardiologists retract syncope paper after realizing data columns weren’t aligned right

Improperly aligned columns have cost researchers at the Mayo Clinic a paper in the Journal of the American College of Cardiology.

The paper originally concluded that fainting spells (syncope) give patients with high blood pressure in their lung arteries poor prognoses, an observation that turned out to be incorrect.

The problem? The group merged two electronic databases, but did not align columns properly, a problem found only after first author Rachel Le revisited the dataset looking to cull more data.

The retraction notice published on May 22 (the one on ScienceDirect is free to air, while the one on the JACC site is behind a paywall): Continue reading Not for the faint of heart: Cardiologists retract syncope paper after realizing data columns weren’t aligned right

Fujii retractions mount

Spring is a time of rebirth and renewal — and, if you are Yoshitaka Fujii, retraction.

We have seen retraction notices in two journals concerning papers by Fujii, the Japanese anesthesiologist who, according to an international group of editors, may ultimately lose some 190 publications to research fraud.

Otoloaryngology — Head and Neck Surgery last month had the following notice for a 2011 article titled “Antiemetic Efficacy of Low-Dose Midazolam in Patients Undergoing Thyroidectomy,” by Fujii and an M. Ikatura (who has not been accused of wrongdoing, as far as we know): Continue reading Fujii retractions mount

Would you pay $63 for a retraction notice?

For $63 plus tax, you can have a single steak with a side order of fried potatoes and a wedge of crisp iceberg lettuce at the famed Peter Luger steakhouse in Brooklyn. Or you can get a peek at one measly retraction notice from Bentham Science Publishers (at least it’s BYOB).

To be fair, the publisher, based in the United Arab Emirates, does offer a free version of the notice on its own website. But Bentham uses the company Ingenta Connect as a go-between to collect fees —  some of which reach $100 per article, according to a company employee — and as far as we can tell, no such gratis access is available through the middleman. Neither does Ingenta direct readers to the free version in its landing page for the notice.

The article in question, “Solubilization and Amorphization of Non Steroidal Anti-Inflammatory Drug with Low Molecular Weight Chitosan for a New Guar-Based Colon Delivery Formulation,” by Kadria A. Elkhodairy, Nahla S. Barakat and Fars K. Alanazi, appeared in the March 2011 issue of Letters in Drug Design & Discovery. The retraction notice reads: Continue reading Would you pay $63 for a retraction notice?

A retracted periodontitis-heart disease paper that didn’t make it into the new AHA review

On Wednesday, the American Heart Association announced something that those of us who’d been reading the medical literature carefully had known for a while: Bad gums do not cause heart disease.

Periodontitis is linked to bad heart disease, you see, as studies have shown, and periodontists have sure been using this as an excuse to tell us to floss. But there’s never been a convincing study showing that one causes the other.

In fact, it’s not even clear how you’d do that study. “Let’s see, for a control group, we should have 100 people convince themselves they’re flossing for a year, but not actually floss….oh, what else can we get funding for?”

That “news” prompted an email from Retraction Watch friend Marc Abrahams, Continue reading A retracted periodontitis-heart disease paper that didn’t make it into the new AHA review

Group investigated by University of Louisville corrects lung cancer paper after retracting six others

A group of researchers whose work has been under investigation at the University of Louisville has issued a correction for a paper in the American Journal of Respiratory Cell and Molecular Biology (AJRCMB).

The correction follows three retractions each in the Journal of Biological Chemistry and the AJRCMB, the latter of which made it clear that lab member ShouWei Han was responsible for the manipulations and duplications that brought down the papers. Here’s the new notice, which appeared in the March 1, 2012 issue of the journal: Continue reading Group investigated by University of Louisville corrects lung cancer paper after retracting six others

Hold the broccoli, garlic, and wine: Three Dipak Das retractions appear in Journal of Agricultural and Food Chemistry

The Journal of Agricultural and Food Chemistry has retracted three papers by Dipak Das, the resveratrol researcher found to have committed more than 100 counts of fraud by the University of Connecticut.

Journal editor James Seiber writes: Continue reading Hold the broccoli, garlic, and wine: Three Dipak Das retractions appear in Journal of Agricultural and Food Chemistry